| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.
|
Lancet
|
2005
|
13.77
|
|
2
|
Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
|
JAMA
|
2011
|
3.88
|
|
3
|
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
|
JAMA
|
2008
|
3.64
|
|
4
|
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.
|
J Am Coll Cardiol
|
2010
|
3.18
|
|
5
|
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2013
|
2.43
|
|
6
|
Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
|
Circulation
|
2010
|
2.27
|
|
7
|
Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis.
|
Circulation
|
2011
|
2.17
|
|
8
|
Smoking, clopidogrel, and mortality in patients with established cardiovascular disease.
|
Circulation
|
2009
|
1.77
|
|
9
|
Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
|
J Am Coll Cardiol
|
2010
|
1.56
|
|
10
|
The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease.
|
Eur Heart J
|
2009
|
1.49
|
|
11
|
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
|
Eur Heart J
|
2013
|
1.49
|
|
12
|
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
|
Am Heart J
|
2011
|
1.47
|
|
13
|
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
|
Am J Cardiol
|
2010
|
1.13
|
|
14
|
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
|
Crit Pathw Cardiol
|
2009
|
1.11
|
|
15
|
Left atrial epicardial adiposity and atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.11
|
|
16
|
Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.
|
J Virol
|
2006
|
0.97
|
|
17
|
Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.
|
Am Heart J
|
2008
|
0.96
|
|
18
|
C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
|
Circulation
|
2013
|
0.95
|
|
19
|
Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
|
Eur J Prev Cardiol
|
2012
|
0.92
|
|
20
|
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
|
Am J Cardiol
|
2009
|
0.85
|
|
21
|
Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.
|
J Infect Dis
|
2006
|
0.85
|
|
22
|
Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection.
|
Vaccine
|
2007
|
0.82
|
|
23
|
Response to Letter by May et al regarding article, "Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation" by Bassiouny et al.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.78
|
|
24
|
Dental development in children with growth hormone insensitivity syndrome: Demirjian analysis of serial panoramic radiographs.
|
Cleft Palate Craniofac J
|
2008
|
0.75
|
|
25
|
Ultrasonic nebulization headspace ionic liquid-based single drop microextraction of flavour compounds in fruit juices.
|
Talanta
|
2013
|
0.75
|
|
26
|
Determination of lignans in Wuweizi by using magnetic bar microextraction and HPLC.
|
J Sep Sci
|
2013
|
0.75
|